Drug Shortage Report for MYLAN-RIZATRIPTAN ODT

Last updated on 2017-09-30 History
Report ID 20578
Drug Identification Number 02379198
Brand name MYLAN-RIZATRIPTAN ODT
Common or Proper name RIZATRIPTAN ODT
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 6BL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-09-08
Actual start date 2017-09-11
Estimated end date 2017-09-29
Actual end date 2017-09-29
Shortage status Resolved
Updated date 2017-09-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-09-30 English Compare
v9 2017-09-29 French Compare
v8 2017-09-29 English Compare
v7 2017-09-28 French Compare
v6 2017-09-28 English Compare
v5 2017-09-13 French Compare
v4 2017-09-13 English Compare
v3 2017-09-09 English Compare
v2 2017-08-29 French Compare
v1 2017-08-29 English Compare

Showing 1 to 10 of 10